Rugby Laboratories, Inc., a prominent player in the pharmaceutical and biotechnology industry, is headquartered in the United States. Founded in 1992, the company has established itself as a leader in providing high-quality laboratory services, specialising in analytical testing and product development for the pharmaceutical sector. With a strong presence across North America and Europe, Rugby Laboratories is renowned for its commitment to innovation and regulatory compliance. The company offers a diverse range of core services, including stability testing, microbiological testing, and method development, all tailored to meet the stringent requirements of its clients. Rugby Laboratories distinguishes itself through its state-of-the-art facilities and a team of experienced professionals dedicated to delivering precise and reliable results. Recognised for its exceptional quality and customer service, Rugby Laboratories continues to solidify its market position as a trusted partner in the pharmaceutical landscape.
How does Rugby Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Rugby Laboratories, Inc.'s score of 70 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Rugby Laboratories, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Cardinal Health, Inc., and therefore, any climate commitments or emissions data may be inherited from its parent organisation. As a part of its corporate family, Rugby Laboratories aligns with the sustainability initiatives and targets set by Cardinal Health, Inc. This includes participation in various climate-related frameworks, such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Cardinal Health at a third-level relationship. However, specific reduction targets or achievements for Rugby Laboratories are not detailed in the available information. While Rugby Laboratories has not disclosed its own emissions or reduction initiatives, it is essential to note that the company is part of a broader commitment to sustainability and climate action through its affiliation with Cardinal Health. This relationship may provide a pathway for future emissions reporting and climate commitments as the industry increasingly prioritises environmental responsibility.
Access structured emissions data, company-specific emission factors, and source documents
| 2009 | 2010 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 148,856,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 212,644,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 00,000,000 | - | - | - | 00,000,000,000 | 00,000,000,000 |
Rugby Laboratories, Inc.'s Scope 3 emissions, which increased by 5% last year and increased significantly since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 93% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Rugby Laboratories, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.